A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

By Matsueda Kei   Harasawa Shigeru   Hongo Michio   Hiwatashi Nobuo   Sasaki Daisuke  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 10, 2008-01 ,pp. : 1202-1211

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

A Randomized, Double-Blind Placebo-Controlled Trial of Iron in Restless Legs Syndrome

By  

European Neurology, Vol. 43, Iss. 2, 2000-02 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial

By Kamischke A  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 596-603

Oxford University Press

Access to resources Recommend Favorite

Clinical Trial: Transcutaneous Interferential Electrical Stimulation in Individuals with Irritable Bowel Syndrome – A Prospective Double-Blind Randomized Study

By  

Digestion, Vol. 86, Iss. 2, 2012-07 ,pp. : 86-93

Karger

Access to resources Recommend Favorite